Cargando…

Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats

BACKGROUND: Diabetes is a major public health concern. In spite of continuous new drug development to treat diabetes, herbal remedies remain a potential adjunct therapy to maintain better glycemic control while also imparting few side-effects. Portulaca oleracea has been traditionally used to manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadan, Basma K., Schaalan, Mona F., Tolba, Amina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225634/
https://www.ncbi.nlm.nih.gov/pubmed/28077129
http://dx.doi.org/10.1186/s12906-016-1530-1
_version_ 1782493549337509888
author Ramadan, Basma K.
Schaalan, Mona F.
Tolba, Amina M.
author_facet Ramadan, Basma K.
Schaalan, Mona F.
Tolba, Amina M.
author_sort Ramadan, Basma K.
collection PubMed
description BACKGROUND: Diabetes is a major public health concern. In spite of continuous new drug development to treat diabetes, herbal remedies remain a potential adjunct therapy to maintain better glycemic control while also imparting few side-effects. Portulaca oleracea has been traditionally used to manage several diseases due to the anti-oxidant and anti-atherogenic effects it imparts. To better understand the mechanisms associated with potential protective effect of P. oleracea extract against diabetes, alloxan-induced diabetic rats were used in this study. METHODS: Forty Wistar rats (male, 7–8-wk-old, 140–160 g) were divided into four groups (n = 10/group): Group I (control), Group II (P. oleracea-treated; gavaged with P. oleracea extract daily [at 250 mg/kg] for 4 weeks), Group III (diabetic control; daily IP injection of alloxan [at 75 mg/kg] for 5 days) and Group IV (P. oleracea-pre-treated diabetic; gavaged with P. oleracea extract daily [at 250 mg/kg] for 4 weeks and then daily IP injection of alloxan [at 75 mg/kg] for 5 days). Body weight, food consumption, blood (serum) levels of glucose, C peptide, Hb A1C, insulin, tumor necrosis factor (TNF)-α and interleukin (IL)-6 were determined for all groups. RESULTS: The results indicated that while Hb A1C, serum levels of glucose, TNF-α and IL-6 were all significantly decreased in the P. oleracea-pre-treated diabetic rats, these hosts also had significant increases in C peptide and insulin compared to levels in the counterpart diabetic rats. These results were confirmed by the histopathological assessments which showed marked improvement of the destructive effect on pancreatic islet cells induced by alloxan. CONCLUSION: P. oleracea extract is a general tissue protective and regeneartive agent, as evidenced by increasing β-cell mass and therefore improved the glucose metabolism. Thus, stimulation of Portulaca oleracea signaling in β- cells may be a novel therapeutic strategy for diabetes prevention.
format Online
Article
Text
id pubmed-5225634
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52256342017-01-17 Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats Ramadan, Basma K. Schaalan, Mona F. Tolba, Amina M. BMC Complement Altern Med Research Article BACKGROUND: Diabetes is a major public health concern. In spite of continuous new drug development to treat diabetes, herbal remedies remain a potential adjunct therapy to maintain better glycemic control while also imparting few side-effects. Portulaca oleracea has been traditionally used to manage several diseases due to the anti-oxidant and anti-atherogenic effects it imparts. To better understand the mechanisms associated with potential protective effect of P. oleracea extract against diabetes, alloxan-induced diabetic rats were used in this study. METHODS: Forty Wistar rats (male, 7–8-wk-old, 140–160 g) were divided into four groups (n = 10/group): Group I (control), Group II (P. oleracea-treated; gavaged with P. oleracea extract daily [at 250 mg/kg] for 4 weeks), Group III (diabetic control; daily IP injection of alloxan [at 75 mg/kg] for 5 days) and Group IV (P. oleracea-pre-treated diabetic; gavaged with P. oleracea extract daily [at 250 mg/kg] for 4 weeks and then daily IP injection of alloxan [at 75 mg/kg] for 5 days). Body weight, food consumption, blood (serum) levels of glucose, C peptide, Hb A1C, insulin, tumor necrosis factor (TNF)-α and interleukin (IL)-6 were determined for all groups. RESULTS: The results indicated that while Hb A1C, serum levels of glucose, TNF-α and IL-6 were all significantly decreased in the P. oleracea-pre-treated diabetic rats, these hosts also had significant increases in C peptide and insulin compared to levels in the counterpart diabetic rats. These results were confirmed by the histopathological assessments which showed marked improvement of the destructive effect on pancreatic islet cells induced by alloxan. CONCLUSION: P. oleracea extract is a general tissue protective and regeneartive agent, as evidenced by increasing β-cell mass and therefore improved the glucose metabolism. Thus, stimulation of Portulaca oleracea signaling in β- cells may be a novel therapeutic strategy for diabetes prevention. BioMed Central 2017-01-11 /pmc/articles/PMC5225634/ /pubmed/28077129 http://dx.doi.org/10.1186/s12906-016-1530-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ramadan, Basma K.
Schaalan, Mona F.
Tolba, Amina M.
Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title_full Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title_fullStr Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title_full_unstemmed Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title_short Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats
title_sort hypoglycemic and pancreatic protective effects of portulaca oleracea extract in alloxan induced diabetic rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225634/
https://www.ncbi.nlm.nih.gov/pubmed/28077129
http://dx.doi.org/10.1186/s12906-016-1530-1
work_keys_str_mv AT ramadanbasmak hypoglycemicandpancreaticprotectiveeffectsofportulacaoleraceaextractinalloxaninduceddiabeticrats
AT schaalanmonaf hypoglycemicandpancreaticprotectiveeffectsofportulacaoleraceaextractinalloxaninduceddiabeticrats
AT tolbaaminam hypoglycemicandpancreaticprotectiveeffectsofportulacaoleraceaextractinalloxaninduceddiabeticrats